Johnson & Johnson (JNJ)
NYSE • Healthcare
May 20, 2026 at 16:00 UTC
About Johnson & Johnson
Johnson & Johnson is a healthcare company that develops medicines and medical technologies for use in clinical practice. Its model connects research, manufacturing, and patient access so therapies and devices move from trials to everyday care under consistent standards. Teams focus on areas where long-term treatment and careful procedure matter, pairing evidence with clear guidance for clinicians. Supply and quality systems favor steady availability over splashy launches, and education helps professionals apply products safely. Operations span many regions, but the promise is the same: dependable options that fit real care settings and can be supported for the long run. The emphasis is safety, labeling clarity, and continuity in daily use.
Analyst Ratings
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings Calendar
Technical Indicators
Johnson & Johnson's Technical Indicators Summary
Johnson & Johnson presents a bullish technical tone supported by price action above several key moving averages and positive momentum readings, including a modest uptick in momentum and a neutral RSI. ADX does not indicate a strong trend but volume metrics favor accumulation, and the near‑term averages sit below the market while the 200‑day average provides additional support. Volatility is contained relative to price. Technical takeaway: generally bullish, with supportive moving averages and volume underpinning the near‑term uptrend.
| Indicator | Value |
|---|---|
RSI (14) | 51.35 |
Stochastic %K (14, 3, 3) | 69.44 |
CCI (20) | 85.54 |
WPR (14) | -18.18 |
Momentum (10) | 4.45 |
MFI | 40.18 |
MACD Level (12, 26) | -1.57 |
Bollinger Bands | $220.67 - $232.59 |
ATR (14) | $4.13 (1.80%) |
ADX (14) | 18.46 |
OBV | 242,681,688 |
Classic Pivot Point | $228.16 |
Fibonacci Pivot Point | $228.16 |
Simple Moving Averages | $209.83 - $234.03(5 indicators) |
Exponential Moving Averages | $207.45 - $230.85(5 indicators) |
Get premium market insights delivered directly to your inbox.
Today's Snapshot
By the close, JNJ continued to sit slightly below yesterday’s 230.00, with a small -0.27% gap down and a finish near 229.37. Into the bell, a flat sector move (-0.12%) kept the backdrop muted. JNJ modest dip comes as a key holder trims stake while analysts lift price targets and dividend expectations.
Price Change
from $229.36 close
-$0.04
Trading Volume
Below avg (8.2M)
3.3M
vs S&P 500 Today
Underperforming Market
-1.68%
52-Week Position
Upper range
78.2%
Updated: May 20, 2026 at 20:05 UTC
Quote Summary
JNJ Headlines
Health Care Lags SPY At 24-Year Low
May 18, 2026
Nasdaq 100 Soars As JNJ Correlation Flips
May 15, 2026
Big Pharma Updates: Trials, Deals and Ratings
April 27, 2026
Analysts Update Views on Major Blue-Chip Stocks
April 21, 2026